The Birth of a Drug: Regulatory Factors in Vitamin and Herbal Therapy Claims
Aug 15, 2007
13:00
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Host: Michael Greenberg, MD
Guest: Katie MacFarlane, PharmD
Dr. Michael Greenberg talks to Katie MacFarlane, President and CEO of Xintria Pharmaceutical Corporation about the FDA and its involvement in the birth of a new medication and the different rules that vitamins and herbal medications have regarding therapeutic claims.
Clinician's Roundtable